Navigation Links
An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
Date:3/10/2010

gold standard for migraine in 2013, although we forecast its use will be limited owing to its high cost, generics competition, reimbursement challenges and patient preference for oral pills."

About the Report

Migraine (Acute): Neurologists' Expectations for a New Acute Therapy Extend Beyond Cardiovascular Safety is a DecisionBase 2010 report. DecisionBase 2010 is a decision-support tool that provides in-depth analysis of unmet need, physician expectations of new therapies and commercial dynamics to help pharmaceutical companies optimize their investments in drug development. 

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.


'/>"/>
SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
5. Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
8. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
9. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
10. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
11. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... -- Research and Markets  has announced the addition of ... report to their offering. ... drug market has been expanding rapidly owing to the ... During 2005-2013, sales of recombinant protein drugs available in ... and it is projected that China ...
(Date:11/21/2014)... Nov. 21, 2014  Tandem Diabetes Care ® ... medical device company and manufacturer of the t:slim ... with Tidepool, a non-profit dedicated to improving diabetes ... platform that increases diabetes data accessibility. This partnership ... is currently under development, to download and access ...
(Date:11/21/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... the medical, research, and veterinary markets worldwide and providing ... in the United States , announced ... acquire 100% of QCR & Trio Diagnostics Limited, a ... The transaction closed on November 17, 2014. ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
(Date:11/22/2014)... 22, 2014 "My friend went in ... by the machine," said an inventor from Cambria Heights, ... go back a second time because the first results ... She developed the patent-pending MAMO EASY to offer a ... design saves the patient from the pain normally involved ...
(Date:11/22/2014)... WA (PRWEB) November 22, 2014 The ... and complexity of block retaining walls. The article states that, ... there are several necessary steps that go into creating this ... when building a retaining wall is choosing which kind of ... purpose. , B&D Rockeries says, “The two main options ...
(Date:11/22/2014)... UWDress.com is gratified to introduce its new collection of ... company has also offered an attracting discount on these ... of wedding dresses, UWDress.com is good at manufacturing all ... gowns are provided over 20 colors, which have diverse ... famous for high quality. Therefore, its sales increased quickly ...
(Date:11/22/2014)... SAN JOSE, Calif. (PRWEB) November 22, 2014 ... related security applications was announced today which safely ... body using high frequency radio waves. Developed by ... nude images and hosts broad applications in other ... in addition to security. , Using high frequency ...
(Date:11/22/2014)... 22, 2014 A Xarelto lawsuit has been ... is seeking $10 million in damages from the makers and ... to the lawsuit, the woman began using Xarelto in March ... in her lawsuit she suffered life-threatening bleeding in July 2012 ... pain, suffering and emotional distress. The lawsuit purports that the ...
Breaking Medicine News(10 mins):Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4
... awareness campaign extends the mission statement of surgeons and adds great ... ... 24, 2009 -- Dr. Ian Clarke, medical researcher and founder of ... research career involving the wear phenomena of joint replacement bearings. He ...
... ingredients could be sent to manufacturers by month,s end, ... A viable H1N1 swine flu vaccine got a bit ... two promising candidate viruses for use in such a ... candidate vaccine virus," Dr. Anne Schuchat, the Centers for ...
... a well produced audio or video for a internet directory ... attracting clients. Jeff Fisher, the developer of ... the written word can provide when selecting a therapist from ... health professionals. It,s a new phenomenon that is bound ...
... Dr. Kent Erickson was recognized as the ... Minnesota Chiropractic Association (MCA) during their recent Convention and ... service to the profession, Dr. Erickson has been a ... years. During his tenure with the association he has ...
... May 22 Helen Darling, President of the National ... NBGH is the national association representing 300 large ... providing health benefits to more than 55 million Americans ... press release responding to what we believed were some ...
... more intrinsic goals is what leads to well-being , , FRIDAY, ... looks and fame may sound like a sure ticket to ... the University of Rochester in New York tracked 147 college ... in time -- one year after graduation, and then 12 ...
Cached Medicine News:Health News:Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist 2Health News:Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist 3Health News:U.S. Progressing on Swine Flu Vaccine 2Health News:U.S. Progressing on Swine Flu Vaccine 3Health News:U.S. Progressing on Swine Flu Vaccine 4Health News:U.S. Progressing on Swine Flu Vaccine 5Health News:U.S. Progressing on Swine Flu Vaccine 6Health News:U.S. Progressing on Swine Flu Vaccine 7Health News:U.S. Progressing on Swine Flu Vaccine 8Health News:U.S. Progressing on Swine Flu Vaccine 9Health News:U.S. Progressing on Swine Flu Vaccine 10Health News:U.S. Progressing on Swine Flu Vaccine 11Health News:U.S. Progressing on Swine Flu Vaccine 12Health News:U.S. Progressing on Swine Flu Vaccine 13Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 2Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 3Health News:Looks, Money, Fame Don't Bring Happiness 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: